Literature DB >> 2439609

Selective suppression of two postnatally acquired 70 kD and 65 kD keratin proteins during continuous treatment of adult mouse tail epidermis with vitamin A.

J Schweizer, G Fürstenberger, H Winter.   

Abstract

Using mouse tail epidermis as a model system we have studied the morphologic and biochemical effects of continuous topical treatment with vitamin A acid. Normal tail epidermis shows a regular pattern of parakeratotic scale regions and orthokeratotic interscale regions which arise postnatally from a uniformly orthokeratinizing neonatal epidermis. Daily treatment of tail epidermis with vitamin A acid for 14 days results in the induction of hyperplasia and the orthokeratotic conversion of the scale regions. The degree of these alterations is dose-dependent and maximally brought about by repetitive 30-microgram doses of the vitamin. To correlate morphologic with biochemical alterations, we have analyzed the keratin patterns of normal and vitamin A acid-treated epidermis by one- and two-dimensional gel electrophoresis. The results indicate that repetitive vitamin A treatment leads to the selective suppression of two postnatally acquired 70 kD and 65 kD type II keratin proteins. Again the minimum repetitive dose required for their complete suppression is 30 micrograms vitamin A acid. Kinetic studies reveal an initial lag phase of 6 days of apparent nonresponsiveness, followed by a 5-day period during which the adult pattern is gradually replaced by the neonatal pattern. Repetitive treatment of tail epidermis with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate leads to a strong hyperplasia; however, it strictly maintains the scale parakeratosis. Under these conditions only the 70 kD keratin subunit is suppressed. This indicates that the suppression of the 70 kD keratin is generally linked to the induction of hyperproliferation, whereas the suppression of the scale-associated 65 kD subunit is due to the metaplastic potency of vitamin A. We provide evidence that this vitamin A-specific in vivo effect can be used to determine the biologic activity of synthetic retinoids relative to vitamin A acid.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439609     DOI: 10.1111/1523-1747.ep12470544

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Retinoid-mediated transcriptional regulation of keratin genes in human epidermal and squamous cell carcinoma cells.

Authors:  V Stellmach; A Leask; E Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

2.  Structure and site of expression of a murine type II hair keratin.

Authors:  E Tobiasch; J Schweizer; H Winter
Journal:  Mol Biol Rep       Date:  1992-02       Impact factor: 2.316

3.  A 5'-upstream region of a bovine keratin 6 gene confers tissue-specific expression and hyperproliferation-related induction in transgenic mice.

Authors:  A Ramírez; M Vidal; A Bravo; F Larcher; J L Jorcano
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

4.  The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin.

Authors:  Iwona Driskell; Hisanobu Oda; Sandra Blanco; Elisabete Nascimento; Peter Humphreys; Michaela Frye
Journal:  EMBO J       Date:  2011-11-25       Impact factor: 11.598

5.  The interfollicular epidermis of adult mouse tail comprises two distinct cell lineages that are differentially regulated by Wnt, Edaradd, and Lrig1.

Authors:  Céline Gomez; Wesley Chua; Ahmad Miremadi; Sven Quist; Denis J Headon; Fiona M Watt
Journal:  Stem Cell Reports       Date:  2013-06-04       Impact factor: 7.765

6.  Transient elevation of cytoplasmic calcium ion concentration at a single cell level precedes morphological changes of epidermal keratinocytes during cornification.

Authors:  Teruasa Murata; Tetsuya Honda; Gyohei Egawa; Yasuo Yamamoto; Ryo Ichijo; Fumiko Toyoshima; Teruki Dainichi; Kenji Kabashima
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.